<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000630970"><TermName>MDR modulator CBT-1</TermName><TermPronunciation>(… MAH-juh-lay-ter …)</TermPronunciation><TermDefinition><DefinitionText>A substance taken from plants that is being studied in the treatment of cancer. It may help drugs kill tumor cells that have become resistant to drugs. It is a type of multidrug resistance inhibitor and a type of P-glycoprotein antagonist.  Also called CBT-1.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722593" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;MDR modulator CBT-1&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722594" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;modulador de RMF CBT-1&quot;" language="es" id="_4"/><SpanishTermName>modulador de RMF CBT-1</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia que se toma de las plantas y que está en estudio para el tratamiento de cáncer. Podría ayudar a los medicamentos a destruir las células que se han vuelto resistentes. Es un tipo de inhibidor de la resistencia que ofrecen algunas células a una combinación de medicamentos y un tipo de antagonista de la glucoproteína P. También se llama CBT-1.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-12-29</DateFirstPublished></GlossaryTerm>
